C
ardiomyocytes withdraw from the cell cycle after birth, and the postnatal heart grows by cellular hypertrophy rather than by cell division. [1] [2] [3] [4] Because loss of cardiomyocytes is the most prominent feature of congestive heart failure, a major cause of morbidity and mortality in the United States, considerable effort has been devoted to examining the proliferative capacity of postnatal cardiomyocytes. 5 Several studies suggest that adult cardiomyocytes can be stimulated to synthesize DNA in vitro and in vivo. [5] [6] [7] [8] [9] [10] [11] Although the absolute values of the DNA synthesis index vary, they are generally extremely low. 5 These studies suggest that proliferative capacity may be retained in adult cardiomyocytes, but it is extremely limited in most adult mammal hearts.
In general, the cell cycle is controlled at various cell-cycle checkpoints by cyclins, cyclin-dependent kinases (cdks), and cdk inhibitors. [12] [13] [14] [15] Control of the G1-to S-phase transition is mainly regulated by cdk2, 16 -19 whereas cdc2 plays a critical role in the transition from G2 to M phase. 20 However, in cardiomyocytes, the regulation of the cell-cycle process is not well characterized. Several groups have shown that overexpression of cell-cycle regulators induces DNA synthesis in cardiomyocytes. [21] [22] [23] [24] Transgenic models expressing high levels of c-myc mRNA resulted in a 2-fold increase in cardiomyocyte number in the fetus. 25, 26 Increased incorporation of bromodeoxyuridine (BrdU), a marker of DNA synthesis, and increased cardiomyocyte numbers were observed in insulin growth factor-1 transgenic mice. 27 Furthermore, Soonpaa et al 28 reported that overexpression of cyclin D1 promotes cardiomyocyte DNA synthesis and multinucleation. These studies indicate that altered levels of cell-cycle regulators can increase DNA synthesis and possibly increase cardiomyocyte numbers. In this study, we examined the effect of cardiacspecific overexpression of cdk2 on DNA synthesis and cell-cycle regulation in adult cardiomyocytes.
Materials and Methods

Reagents and Chemicals
Anti-human cyclophilin A was purchased from Upstate Biotechnology as an internal control for protein loading and transfer. Other antibodies and chemicals were obtained as described previously. 29 
Generation and Identification of cdk2 Transgenic Mice
Total RNA was isolated from ventricular tissue using Tri reagent (Sigma) according to the manufacturer's protocol. Total RNA (20 g/lane) was separated by electrophoresis using 1% denatured gels and then blotted onto Hybond Nylonϩ membrane and probed to GAPDH, cdk2, ␤-MHC, and atrial natriuretic factor (ANF). 32, 33 The hybridization signals were detected by exposing a film overnight.
Total proteins extracted from ventricles were analyzed for expression of cdk2, cdc2, cdk4, and cyclins by immunoblotting as described previously. 29 For the cdk2 kinase assay, immunoprecipitation was performed using cdk2 antibody. The immunocomplex was incubated with histone H1, as described previously. 29 
Dispersed Cardiomyocyte Preparations, Nuclear Staining, and Area Analysis
Highly pure adult cardiomyocytes were prepared by enzymatic dissociation using retrograde perfusion with collagenase, 34, 35 and the isolated cardiomyocytes were plated on laminin-coated dishes. Nuclear staining was done with Hoechst 33258. Nuclei per cell were counted under a fluorescent microscope. The surface area of individual cardiomyocytes was analyzed using an National Institutes of Health program.
Bromodeoxyuridine Incorporation, Nuclear Density, and DNA Content Three-month-old wild-type (WT) and cdk2 Tg mice were injected intraperitoneally once a day with BrdU (100 mg/kg body weight) for 3 consecutive days. The heart was perfusion-fixed with 4% paraformaldehyde, paraffin-embedded, and sectioned at standard locations including both ventricles and the interventricular septum. The incorporation of BrdU was detected with a mouse monoclonal anti-BrdU antibody (Sigma) and a fluorescent-labeled donkey antimouse IgG secondary antibody. The sections were counterstained with propidium iodide dye and troponin T antibody to identify nuclei and cardiomyocytes, respectively. The results were analyzed by confocal microscopy. Nuclear density was analyzed as described previously. 36 DNA content was determined by a procedure reported previously using crude homogenated heart tissues. 37 
Animal Model of Pressure Overload
Ascending aortic constriction was performed as described previously. 38 
Statistics
Data were analyzed by one-way ANOVA followed by assessment of differences by Duncan's multiple-range tests. PϽ0.05 was considered statistically significant.
Results
Generation of Cardiac-Specific cdk2 Tg and Baseline Analysis
To create mice in which cdk2 is specifically overexpressed in cardiomyocytes, we used the ␣-MHC promoter ( Figure  1A) . 30, 31 Eight lines of animals that exhibited germ-line transmission were generated, and 3 lines of cdk2 transgenic mice were used for additional analysis. All 3 lines of cdk2 Tg expressed high levels of cdk2 mRNA and proteins in adult hearts but not in adult WT hearts ( Figures 1B and 1C) . Cdk2 activity could not be detected in adult WT heart, as determined by cdk2 kinase assay using histone H1 as a substrate ( Figure 1D ). In contrast, adult cdk2 Tg expressed high levels of cdk2 activity, indicating that overexpressed cdk2 proteins were catalytically active.
No cdk2 Tg mice were prone to early lethality over 1 year of observation. Gross cardiac defects and histological evidence of ventricular hypertrophy or fibrosis were absent in adult cdk2 Tg hearts. The ratio of heart weight to body weight (HW/BW) of cdk2 Tg did not differ from that of WT in adults ( Figure 2A) . However, the HW/BW ratio in cdk2 Tg mice was significantly increased on neonatal day 2 but not on neonatal day 5 or 10 ( Figure 2A ). To investigate whether the cardiac-specific overexpression of cdk2 would affect in vivo cardiac function, we performed echocardiography on 3-month-old mice. 39 There was no difference in posterior wall thickness in diastole, anterior wall thickness in diastole, left ventricular dimension in diastole, and left ventricular dimension in systole and endocardial fractional shortening between WT and cdk2 Tg at baseline (Table 1) . Therefore, global cardiac structure and cardiac function were normal in adult cdk2 Tg.
Increases of DNA Synthesis in Adult cdk2 Tg Heart
To determine whether overexpression of cdk2 promotes DNA synthesis in adult heart, we first examined the DNA content by staining a crude homogenated adult heart tissue with Hoechst dye. 37 Cdk2 Tg and WT mice did not differ in the DNA content of heart tissues (WTϭ3.97Ϯ0.27; cdk2 Tgϭ3.76Ϯ0.39 g DNA/mg heart tissues, nϭ6, PϭNS). Next, we measured the nuclear density using adult heart section. There was also no significant difference in nuclear density between adult WT and cdk2 Tg (WTϭ2350Ϯ557; cdk2 Tgϭ2257Ϯ432 nuclei/mm 2 , nϭ6, PϭNS). Finally, we analyzed DNA synthesis using the incorporation of BrdU into newly synthesized DNA. 36 We found that the ventricular labeling index was 0.06Ϯ0.007% in cdk2 Tg, which was Ͼ100 times higher than that of age-matched WT mice (cdk2 Tgϭ23Ϯ3 BrdU-positive cardiac nuclei/4ϫ10 4 total nuclei versus WTϭ2Ϯ4.2 BrdU-positive cardiac nuclei/4ϫ10 5 total nuclei, nϭ10, PϽ0.001). These findings indicate that overexpression of cdk2 increased DNA synthesis in adult hearts by a very limited amount.
Because proliferating cell nuclear antigen (PCNA) is a component of the DNA replication fork that is required for both DNA synthesis and repair, we measured the expression of PCNA at different developmental stages. WT and cdk2 Tg mice expressed equally high levels of PCNA proteins in the heart at embryonic day 18 (E18) ( Figure 2B ). In contrast, at neonatal day 2, there was significantly higher expression of PCNA in cdk2 Tg than in WT heart ( Figures 2B and 2C) . Thus, the stage-specific increase in cardiac mass ( Figure 2A ) is consistent with the differential expression of PCNA in neonatal cdk2 Tg (see Discussion). More modest but also significant increases of PCNA were found at neonatal days 5 and 10 and in the adult ( Figures 2B and 2C ).
Increases in the Proportion of Smaller Mononuclear Cardiomyocytes in Adult cdk2 Tg
In the murine fetus, almost all cardiomyocytes are mononuclear, whereas in the adult, Ͼ90% are binuclear, 3, 40 suggesting that binucleation of the cardiomyocyte is associated with cardiomyocyte maturation. Therefore, we asked whether overexpression of cdk2 affects nucleation of individual cardiomyocytes. We counted the nuclei of isolated adult cardiomyocytes by staining with Hoechst. In agreement with the previous reports, the large majority of cardiomyocytes in the adult WT heart was binuclear; only 8% of cardiomyocytes were mononuclear 3, 40 ( Figures 3A and 3B) . Interestingly, in cdk2 Tg mice, there was a marked increase in the relative proportion of mononuclear cardiomyocytes (45%) with a concomitant decrease in the binuclear cardiomyocytes (Figures 3A and 3B ). There was no change in the number of cardiomyocytes with Ͼ2 nuclei ( Figure 3B ).
Other investigators showed that overexpression of G1-to S-phase cell-cycle regulators decreased cell size in vitro. [41] [42] [43] Therefore, to examine whether overexpression of cdk2 would also affect cardiomyocyte size in our model, we measured a 2-dimensional surface area of cardiomyocytes isolated from adult hearts. Quantitative analysis indicated that the surface areas of adult cdk2 cardiomyocytes were significantly smaller 
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compared with those of WT cardiomyocytes ( Figure 3C ). The size distribution of cardiomyocytes in cdk2 Tg was shifted to the left compared with WT, additionally supporting this finding ( Figure 3D ). In general, the mononuclear cardiomyocytes were smaller than binuclear cardiomyocytes ( Figure  3A) . The quantitative analysis showed that cell size of mononuclear cardiomyocytes was 60% of binuclear cardiomyocytes in cdk2 Tg, suggesting that overall decrease in cell size in cdk2 Tg may be predominately attributable to increase in the proportion of mononuclear cardiomyocytes.
To asses the maturation of cardiomyocytes in adult cdk2 Tg, we measured the expression of cardiac fetal markers, such as ANF and ␤-MHC, by Northern blot analysis using whole ventricle tissues. In adult WT hearts, the expression of ANF and ␤-MHC genes was not detectable (Figure 4) . However, despite the fact that there was no evidence of hypertrophy or heart failure, the expression of both genes was increased in adult cdk2 Tg hearts, suggesting that the overexpression of cdk2 may disturb maturation of adult cardiomyocytes.
Expression of Cell-Cycle Regulators in Adult cdk2 Tg
To additionally explore how cdk2 overexpression affects cell-cycle regulation in cardiomyocytes on a molecular level, we examined the expression of several cell-cycle regulators. Although neonatal WT hearts expressed substantial levels of positive cell-cycle regulators, such as cyclins A, D3, and E, cdk4, and cdc2, the adult hearts expressed undetectable levels, consistent with the cell-cycle withdrawal in adult hearts ( Figure 5 ). In contrast, adult cdk2 Tg hearts were characterized by marked increases of cyclin D3 and cdk4 and modest increases in cyclin A and E expression ( Figure 5 ). This suggests that cdk2 activates the expression of G1-to S-phase cell-cycle regulators. As in WT hearts, cdc2 ( Figure  5 , top right) and cyclin B1 (data not shown) were also undetectable in adult cdk2 Tg hearts, indicating that cdk2 overexpression is insufficient in upregulating the cell-cycle regulators of the G2 to M phase. The expression of p21 and p27 cdk2 inhibitors was unchanged in cdk2 Tg hearts compared with the WT hearts ( Figure 5 ).
Effect of Pressure Overload on cdk2 Tg Mice
To determine the effects of overexpressed cdk2 in response to the biomechanical stress, we induced cardiac hypertrophy by pressure overload using an ascending aortic constriction (AAC). 38 After 7 weeks of AAC, the HW/BW ratio was increased in both cdk2 Tg and WT compared with shamoperated mice hearts (Table 2) . However, cdk2 Tg showed a significantly greater increase in heart weight (cdk2 Tgϭ174.1Ϯ19.6 versus WTϭ146.6Ϯ21.4 mg, nϭ10, PϽ0.05). The lung weight in cdk2 Tg was also significantly increased compared with WT in response to pressure overload (cdk2 Tgϭ175.3Ϯ13.3 versus WTϭ156.8Ϯ7.1 mg, nϭ10, PϽ0.05). Echocardiography showed that pressure overload caused a greater increase in the posterior and anterior wall thickness of cdk2 Tg mice than that of WT mice. However, there was a significant decrease in the fraction shortening after 7 weeks of ascending aortic constriction in cdk2 Tg mice, suggesting a left ventricle failure. There was no significant difference in body weight or liver weight, suggesting the absence of significant right ventricular failure. Nuclear staining analysis demonstrated that pressure overload did not change the relative distribution of individual cardiomyocyte nuclei (compare Figures 3B and 6B ). Pressure overload also had no effect on PCNA and cdc2 expression in either WT or cdk2 Tg ( Figure 6C ). Moreover, pressure overload did not significantly increase the BrdU incorporation in cdk2 Tg compared with nonbanding cdk2 Tg (23Ϯ3 BrdU-positive cardiac nuclei/4ϫ10 4 total nuclei in cdk2 Tg at the baseline vs 25Ϯ2 BrdU-positive cardiac nuclei/4ϫ10 4 total nuclei in cdk2 Tg after AAC, nϭ10, Pϭ0.12). The expression of ␤-MHC and ANF in cdk2 Tg mice hearts increased additionally in response to pressure overload (Figure 4) . Interestingly, there was greater relative hypertrophic growth in mononuclear than binuclear cardiomyocytes in response to pressure overload compared with sham-operated cdk2 Tg hearts ( Figures 6A and 6D) . The results indicate that pressure overload in cdk2 Tg mice did not alter the proportion of mononuclear cardiomyocytes. Compared with binuclear cardiomyocytes, pressure overload did cause greater hypertrophy of the mononuclear cardiomyocytes. Cdk2 mice were also more susceptible to left ventricular dysfunction in response to hypertrophic stimuli.
Discussion
In the present study, cardiac-specific overexpression of cdk2 resulted in increased numbers of smaller mononuclear cardiomyocytes and suggestion of a less-differentiated adult heart. There was also evidence of increased DNA synthesis and altered cell-cycle regulators favoring the G1 to S phase. Because the adult cdk2 Tg heart weight was unchanged but the cells were smaller compared with WT mice, there was most likely a total increase in the numbers of cardiomyocytes in cdk2 Tg hearts. In fact, hemocytometer cell counts of dispersed cell preparation showed that there was a 42% increase in the total number of cardiomyocytes in cdk2 Tg mice compared with age-matched WT mice (1.7ϫ10 7 Ϯ1.3ϫ 10 5 in cdk2 Tg versus 1.2ϫ10 7 Ϯ1ϫ10 5 in WT, nϭ6, PϽ0.001). This finding is in agreement with previous reports WT and cdk2 Tg mice were subjected to ascending aortic constriction. After 7 weeks, the body, heart, lung, and liver weights were weighted. Data are meanϮSD. Statistical analysis was performed. PϽ0.05 was considered statistically significant. 
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that overexpression of G1-phase cell-cycle regulators shorten the G1 phase and decreases cell size [41] [42] [43] and that loss of p27, a major cdk2 inhibitor, increases cell numbers but decreases the cell size in hearts. 44 -47 Potential increase in cell numbers in cdk2 Tg hearts could occur in 3 developmental periods. First, cell number could increase in the embryonic stage. Although the notion that ␣-MHC promoter is only activated in the ventricles after birth has been challenged, 30, 31, 48 the expression of cdk2 in the cdk2 Tg at E18 was not significantly different than the WT littermates (data not shown). Thus, cdk2 is not overexpressed at this stage in cdk2 Tg hearts. Second, the cell division may occur in adulthood. The BrdU labeling index of cardiomyocytes was 0.00005% in 3-month-old control littermates. However, the index in cdk2 Tg was increased to 0.06%, which is consistent with previous reports that overexpression of cyclin D1 promotes DNA synthesis in adult hearts. 28 The increased expression of PCNA produces independent molecular evidence of DNA synthesis. However, the absolute value of the BrdU index was still very low compared with that of dividing cells. 49, 50 Thus, the proliferative capacity of adult cdk2 Tg cardiomyocytes still seems to be extremely limited. The most likely scenario is that overexpression of cdk2 causes additional rounds of cardiomyocyte replication in the neonatal period, when ␣-MHC becomes activated. This hypothesis is supported by the significantly increased HW/BW ratio and PCNA expression at neonatal day 2 ( Figure 2 ). At neonatal day 2, most cardiomyocytes are mononuclear 1, 3 ; therefore, cdk2 Tg heart weights would be greater than WT, because cdk2 Tg may have more cells. In the p27 knockout, cardiomyocytes undergo 1 or 2 additional cell divisions before they withdraw from the cell cycle. 51, 52 Thus, the phenotypes of cdk2 Tg mice resemble those of p27 knockout mice.
Overexpression of cdk2 revealed a significant accumulation of mononucleated cardiomyocytes in adult hearts, which contrasts with the increase in multinucleated cardiomyocytes associated with cyclin D1 overexpression. 28 Two possibilities for this phenomenon can be postulated. First, overexpression of cdk2 may delay cardiomyocyte terminal differentiation and subsequently increase cell numbers in adult cdk2 Tg hearts. In cdk2 Tg mice, hypertrophy growth may be limited by an organ size control. 34, 53 Thus, the smaller mononuclear cardiomyocytes are prevented from completely differentiating to become binuclear cardiomyocytes and persist in a less-differentiated state. This is consistent with the finding that constitutive overexpression of cdk2 inhibits differentiation of rat pheochromocytoma PC12 cells. 54 This scenario is also supported by the fact that the expression of fetal genes, such as ANF and ␤-MHC, is significantly increased in adult cdk2 Tg hearts. This result contrasts the previous finding that cyclin D1 Tg had no fetal gene activation. 28 The second possibility is that overexpression of cdk2 may inhibit the formation of binucleate cells, because the decline in cdk2 abundance and activity coincides with binucleation during murine development. 55 To determine whether hypertrophic growth can stimulate DNA synthesis in cdk2 Tg cardiomyocytes, we tested the effect of pressure overload on cdk2 Tg. Pressure overload did not change the proportion of mononuclear and multinuclear cardiomyocytes and BrdU incorporation. This result is consistent with a previous report that there was no significant difference between the ratio of mononucleate and binucleate cardiomyocytes in control and hypertrophic hearts; in addition, no DNA synthesis occurred in response to hypertrophic stimuli. 40 Previous studies demonstrated that hypertrophic growth stimulated PCNA expression in adult hearts and may be attributable to fibroblast proliferation. 5 However, in the present study, we did not find a significant increased expression of PCNA after 7 weeks of AAC. One possibility for this is that the window of reactive PCNA or DNA synthesis may have been missed, because most hypertrophic growth occurred within 3 weeks after pressure overload. 56 Acute pressure overload resulted in an exaggerated hypertrophic response, mainly from smaller, mononuclear cardiomyocytes. This hypertrophic response, compared with normal WT cardiomyocytes, seemed maladaptive and resulted in increased left ventricular dysfunction.
Transgenic models have been widely applied in the field of cardiovascular research. 57 It is generally accepted that experimental and control animals differ only by the presence or absence of the transgene in transgenic mice. 57 Any phenotypic difference observed in the 2 groups are attributable, either directly or indirectly, to the transgene expression. Consequently, nontransgenic littermates are generally used as an internal control. However, we have recently demonstrated that cardiac-specific overexpression of green fluorescence protein, a molecule presently believed to be biologically inert, resulted in a dilated cardiomyopathy when the levels of green fluorescence protein expression is very high. 58 Therefore, using cdk2 kinase-mutant transgenic mice as a control would make the conclusion much stronger than using a nontransgenic littermate control. This remains to be done. It should be noted, however, that the phenotype of cdk2 Tg mice, an increase in mononuclear myocytes, is unique and thus less likely to be a nonspecific response to a foreign gene in the heart.
Overexpression of cdk2 significantly increased the D-type cyclin 3 and cdk4 ( Figure 5 ), which may phosphorylate pocket proteins and disrupt the complex of pocket proteins and E2F transcription factors. The expression of cyclins A and E was significantly increased in cdk2 Tg compared with WT mice (Figure 5 ). This finding is important, because cyclins A and E are the partners of cdk2 in the cell-cycle process. However, the expression of G2-to M-phase cellcycle regulators, such as cdc2 and cyclin B1, was not observed in adult cdk2 Tg, suggesting that overexpression of cdk2 was not able to overcome the G2-to M-phase block.
The mechanism of cell-cycle withdrawal in cardiomyocytes is complicated and poorly understood. The present study suggests a possible role of cdk2 in overcoming G1-to S-phase block in cardiomyocytes. However, additional studies are needed to show whether G2-to M-phase block can be overcome.
